@article{gin_petzold_uthappa_neighbors_borough_gin_lashnits_sempowski_denny_bienzle_et al._2023, title={Evaluation of SARS-CoV-2 identification methods through surveillance of companion animals in SARS-CoV-2-positive homes in North Carolina, March to December 2020}, volume={11}, ISSN={["2167-8359"]}, DOI={10.7717/peerj.16310}, journal={PEERJ}, author={Gin, Taylor E. and Petzold, Elizabeth A. and Uthappa, Diya M. and Neighbors, Coralei E. and Borough, Anna R. and Gin, Craig and Lashnits, Erin and Sempowski, Gregory D. and Denny, Thomas and Bienzle, Dorothee and et al.}, year={2023}, month={Oct} }
 @article{gin_lashnits_wilson_breitschwerdt_qurollo_2021, title={Demographics and travel history of imported and autochthonous cases of leishmaniosis in dogs in the United States and Canada, 2006 to 2019}, volume={35}, ISSN={["1939-1676"]}, url={https://doi.org/10.1111/jvim.16071}, DOI={10.1111/jvim.16071}, abstractNote={Abstract Background Leishmania infantum infections are reported in foxhounds throughout the United States (US) and Canada, but only rarely in other dog breeds. A seroprevalence report from 2006 documented leishmaniosis in foxhounds (8.9%) tested in the US between 2000 and 2003. All other breeds were seronegative. Objective To reexamine demographics and travel history of L. infantum ‐infected dogs in the US and Canada, we hypothesize detection of L. infantum in more foxhounds than nonfoxhounds and that infected nonfoxhounds will have traveled to endemic regions. Animals A total of 125 dogs positive for L. infantum by immunofluorescent antibody, PCR, or both. Methods Retrospective, descriptive study of L. infantum ‐infected dogs between 4 January 2006 and 22 May 2019. Travel history and known lineage to foxhounds was collected from questionnaires. Results Leishmania infantum was detected in 125 (6.4%) of 1961 dogs tested between 4 January 2006 and 22 May 2019, of which 10 (8%) were foxhounds and 115 (92%) were nonfoxhound breeds. Travel history available for 69 (55%) dogs showed 60 (86.9%) dogs had traveled outside of the US or Canada. Nine (13%) dogs had not traveled outside of the US or Canada, 5 of which were nonfoxhounds. Conclusions and Clinical Importance The majority of L. infantum cases were detected in nonfoxhounds, many of which had traveled to L. infantum ‐endemic countries, and several nonfoxhound breeds had no travel history. Leishmania surveillance should be considered for dogs that return from L. infantum ‐endemic regions to monitor emergence of this zoonotic disease in the US and Canada.}, number={2}, journal={JOURNAL OF VETERINARY INTERNAL MEDICINE}, publisher={Wiley}, author={Gin, Taylor Estes and Lashnits, Erin and Wilson, James M. and Breitschwerdt, Edward B. and Qurollo, Barbara}, year={2021}, month={Mar}, pages={954–964} }
 @article{sztukowski_gin_neel_lunn_2021, title={Simultaneous primary hyperparathyroidism and multiple myeloma in a dog with hypercalcaemia}, volume={10}, ISSN={["2052-6121"]}, url={http://www.scopus.com/inward/record.url?eid=2-s2.0-85116385879&partnerID=MN8TOARS}, DOI={10.1002/vrc2.198}, abstractNote={Abstract A 14‐year‐old male castrated Pomeranian was found to be hypercalcaemic and hyperglobulinaemic during investigation of anorexia and haematochezia. Ionised hypercalcaemia, increased serum parathyroid hormone concentration, normophosphatemia and a parathyroid nodule found on cervical ultrasound examination were diagnostic for primary hyperparathyroidism (PHPT). Thoracic radiographs revealed ovoid lytic lesions in multiple bones. To investigate the hyperglobulinaemia, serum electrophoresis and immunoglobulin (Ig) quantification were performed, revealing an IgA biclonal gammopathy. Bone marrow cytopathology confirmed multiple myeloma (MM). Following bilateral parathyroidectomy, the dog's hypercalcaemia resolved, and pulse‐dose chemotherapy with prednisone and melphalan was initiated to treat MM. To the authors' knowledge, this is a unique case report of simultaneous PHPT and MM in the veterinary literature, diseases that are rarely reported concurrently in humans. This case highlights the need to thoroughly investigate multiple problems when they are not explained by a single diagnosis.}, number={4}, journal={VETERINARY RECORD CASE REPORTS}, author={Sztukowski, Keira and Gin, Taylor and Neel, Jennifer and Lunn, Katharine}, year={2021}, month={Oct} }
 @article{gin_secoura_harris_vaden_2020, title={Outcomes Following Balloon Dilation of Benign Urethral Strictures in Dogs: Eight Cases (2005-2018)}, volume={56}, ISSN={["1547-3317"]}, DOI={10.5326/JAAHA-MS-6935}, abstractNote={ABSTRACT Balloon dilation has been described infrequently as a treatment for benign urethral strictures in dogs but is often a first-line therapeutic option for humans. Additional evidence is needed to evaluate the potential role of this procedure in veterinary medicine. The aim of the study was to describe the techniques used and evaluate the response to balloon dilation of benign urethral strictures in dogs. Medical records were reviewed from eight client-owned dogs who underwent balloon dilation of a benign urethral stricture over a 13 yr period in this retrospective case series. Clinical signs improved for five of eight dogs after a single balloon dilation during a follow-up period of 1 wk to 3 yr. After a second procedure, an additional dog demonstrated improvement for 5.5 yr. Adverse outcomes included urinary incontinence in two dogs and recurrent bacteriuria in four dogs. Findings suggest that balloon dilation is an effective, minimally invasive procedure for the treatment of benign urethral strictures in dogs. Urinary incontinence, urinary tract infection, and stricture recurrence are potential outcomes for dogs undergoing this procedure either as a result of the nature of the underlying disease or as a result of the procedure.}, number={1}, journal={JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION}, author={Gin, Taylor Estes and Secoura, Patty and Harris, Tonya and Vaden, Shelly}, year={2020}, pages={23–29} }